Pull to refresh
Logo
Daily Brief
Following
Why Ranks Sign Up
Altaris, LLC

Altaris, LLC

Healthcare investment firm

Appears in 1 story

Stories

Altaris takes drug-simulation software maker Simulations Plus private

Money Moves

Acquirer

Simulations Plus has traded on the Nasdaq stock market since 2004. On June 16, 2026, it agreed to leave public markets. The healthcare investment firm Altaris will buy the drug-simulation software maker for about $375 million and take it private.

Updated Yesterday